IQVIA Holdings Past Earnings Performance
Past criteria checks 5/6
IQVIA Holdings has been growing earnings at an average annual rate of 5.2%, while the Life Sciences industry saw earnings growing at 27.3% annually. Revenues have been growing at an average rate of 8.6% per year. IQVIA Holdings's return on equity is 22.1%, and it has net margins of 8.3%.
Key information
5.2%
Earnings growth rate
9.0%
EPS growth rate
| Life Sciences Industry Growth | 26.8% |
| Revenue growth rate | 8.6% |
| Return on equity | 22.1% |
| Net Margin | 8.3% |
| Last Earnings Update | 30 Sep 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How IQVIA Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 22 | 14,307 | 1,182 | 1,997 | 0 |
| 30 Jun 22 | 14,136 | 1,160 | 1,978 | 0 |
| 31 Mar 22 | 14,033 | 1,079 | 1,977 | 0 |
| 31 Dec 21 | 13,874 | 966 | 1,931 | 0 |
| 30 Sep 21 | 13,536 | 767 | 1,886 | 0 |
| 30 Jun 21 | 12,931 | 607 | 1,848 | 0 |
| 31 Mar 21 | 12,014 | 409 | 1,797 | 0 |
| 31 Dec 20 | 11,359 | 279 | 1,762 | 0 |
| 30 Sep 20 | 10,956 | 176 | 1,759 | 0 |
| 30 Jun 20 | 10,939 | 132 | 1,694 | 0 |
| 31 Mar 20 | 11,158 | 215 | 1,699 | 0 |
| 31 Dec 19 | 11,088 | 191 | 1,711 | 0 |
| 30 Sep 19 | 10,881 | 244 | 1,669 | 0 |
| 30 Jun 19 | 10,706 | 247 | 1,703 | 0 |
| 31 Mar 19 | 10,533 | 248 | 1,691 | 0 |
| 31 Dec 18 | 10,412 | 259 | 1,692 | 0 |
| 30 Sep 18 | 10,245 | 1,217 | 1,738 | 0 |
| 30 Jun 18 | 10,117 | 1,245 | 1,699 | 0 |
| 31 Mar 18 | 9,905 | 1,246 | 1,644 | 0 |
| 31 Dec 17 | 9,702 | 1,277 | 1,605 | 0 |
| 30 Sep 17 | 9,133 | 72 | 1,528 | 0 |
| 30 Jun 17 | 7,804 | 84 | 1,345 | 0 |
| 31 Mar 17 | 6,616 | 108 | 1,192 | 0 |
| 31 Dec 16 | 6,815 | 72 | 1,013 | 0 |
| 30 Sep 16 | 4,540 | 397 | 761 | 0 |
| 30 Jun 16 | 4,497 | 409 | 785 | 0 |
| 31 Mar 16 | 4,404 | 408 | 795 | 0 |
| 31 Dec 15 | 4,326 | 387 | 815 | 0 |
Quality Earnings: QTS has high quality earnings.
Growing Profit Margin: QTS's current net profit margins (8.3%) are higher than last year (5.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: QTS's earnings have grown by 5.2% per year over the past 5 years.
Accelerating Growth: QTS's earnings growth over the past year (54.1%) exceeds its 5-year average (5.2% per year).
Earnings vs Industry: QTS earnings growth over the past year (54.1%) exceeded the Life Sciences industry 12.2%.
Return on Equity
High ROE: Whilst QTS's Return on Equity (22.11%) is high, this metric is skewed due to their high level of debt.